Post-approval trials of new medicines: widening use or deepening knowle?

J.C.F. van Luijn; M. Danz; J.W. Bijlsma; F.W. Gribnau; H.G.M. Leufkens

Post-approval trials of new medicines: widening use or deepening knowle?

J.C.F. van Luijn
, M. Danz
, J.W. Bijlsma
, F.W. Gribnau
, H.G.M. Leufkens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	183-191
Number of pages	9
Journal	Scandinavian Journal of Rheumatology
Volume	40
Issue number	3
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

@article{6077dcd5312c4008a8ecdfaa4c73a510,

title = "Post-approval trials of new medicines: widening use or deepening knowle?",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "\{van Luijn\}, J.C.F. and M. Danz and J.W. Bijlsma and F.W. Gribnau and H.G.M. Leufkens",

year = "2011",

language = "Undefined/Unknown",

volume = "40",

pages = "183--191",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",